Article information
Full text is only aviable in PDF
Bibliografía
[1.]
C. Cunningham-Rundles.
Clinical and immunological analysis of 103 patients with common variable immunodeficiency.
J Clin Immunol, 9 (1989), pp. 22-23
[2.]
J. De Gracia, F. Morell, T. Español, R. Orriols, A. Riba, M.L. Guarner, et al.
Inmunodeficiencia común variable: estudio clínico de 16 casos.
Med Clin (Barc), 91 (1988), pp. 332-337
[3.]
B.E. Chipps, R.C. Talamo, J.A. Winkelstein.
IgA deficiency, recurrent pneumonias and bronchiectasis.
Chest, 73 (1978), pp. 519-526
[4.]
F.M. Schaffer, R.C. Monteiro, J.E. Volanakis, M.D. Cooper.
IgA deficiency.
Immunodeficiency Rev, 3 (1991), pp. 15-44
[5.]
J. De Gracia, M. Miravitlles, M. Vendrell, M.J. Rodrigo, R. Codina, R. Morell.
Estudio de las subclases de la IgG en pacientes con déficit de IgA sintomáticos.
Med Clin (Barc), 104 (1995), pp. 728-731
[6.]
P.H. Schur, H. Borel, E.W. Gelfand, C.A. Alper, F.S. Rosen.
Selective gamma-G globulin deficiencies in patients with recurrent pyogenic infections.
N Engl J Med, 283 (1970), pp. 631-634
[8.]
J. De Gracia, M.J. Rodrigo, F. Morell, M. Vendrell, M. Miravitlles, M.J. Cruz, et al.
IgG subclass deficiences associated with bronchiectasis.
Am J Respir Crit Care Med, 153 (1996), pp. 650-655
[9.]
D.M. Ambrosino, G.R. Siber, B.A. Chilmonczyk, J.B. Jemberg, R.W. Finberg.
An immunodeficiency characterized by impaired antibody responses to polysaccharides.
N Engl J Med, 316 (1987), pp. 790-793
[10.]
Report of a, WHO., Scientific Group.
Primary immunodeficiency diseases, 99 (1995), pp. 2-24
[11.]
J. Björkander, B. Bake, V.A. Oxelius, L.A. Hanson.
Impaired lung function in patients with IgA deficiency and low levels of IgG2, or IgG3.
N Engl J Med, 313 (1985), pp. 720-724
[12.]
J. De Gracia, F. Morell, J.M. Bofill, M.J. Rodrigo, C. Cosculluela.
Impaired lung function in patients with IgA deficiency and low levels of IgG2, or IgG3.
N Engl J Med, 314 (1986), pp. 925-926
[13.]
J. De Gracia, M. Vendrell, L. Guarner, R. Vidal, M. Miravitlles, C. Mayordomo, et al.
Utilización de gammaglobulina humana en el tratamiento de la inmunodeficiencia común variable.
Med Clin (Barc), 104 (1995), pp. 201-206
[14.]
M.J. Rodrigo, R. Codina, J. Gracia, F. Morell, C. Pascual.
Valores normales de las subclases de la inmunoglobulina G en una población de adultos. Su importancia en el estudio de los déficit de las mismas.
Med Clin (Barc), 98 (1992), pp. 166-170
[15.]
C. Feldman, A. Wadee, C. Smith, S. Zwi, G. Immunoglobulin.
(IgG) subclass levels in respiratory disorders.
Respir Med, 86 (1992), pp. 3-5
[16.]
T. Pressler, V. Mansa, S.S. Pedersen, F. Espersen, N. Hoiby, C. Koch.
Methodologic problems in establishing normal values for IgG subclass concentrations in a pediatric population: comparison of radial immunodifusion and ELISA methods.
Allergy, 49 (1994), pp. 772-777
[17.]
A. Vlug, E.J. Nieuwenhuys, R.V. Van Eijk, H.G. Geertzen, A.J. Van Houte.
Nephelometric measurements of human IgG subclasses and their reference ranges.
Ann Biol Clin, 52 (1994), pp. 561-567
[18.]
A. Ferrante, L.J. Beard.
IgG subclass assays with polyclonal antisera and monoclonal antibodies.
Monogr Allergy, 23 (1988), pp. 60-72
[19.]
V.A. Oxelius, B. Laurell, B. Lindquist, H. Golebiowska, U. Axelsson, J. Bjorkander, et al.
IgG subclasses in selective IgA deficiency. Importance of IgG2,-IgA deficiency.
N Engl J Med, 304 (1981), pp. 1.476-1.477
[20.]
A. Plebani, V. Monafo, M.A. Avanzini, A.G. Ugazio, G.R. Burgio.
Relationship between IgA and IgG subclass deficiencies: a reappraisal.
Monogr Allergy, 20 (1986), pp. 171-178
[21.]
R.K. Chandra.
Serum levels and synthesis of IgG subclasses in small-for-gestation low birth weight infants and in patients with selective IgA deficiency.
Monogr Allergy, 20 (1986), pp. 90-99
[22.]
M.A.H. French, G. Harrison.
An investigation into the effect of the IgG antibody system on the susceptibility of IgA-deficient patients to respiratory tract infections.
Clin Exp Immunol, 66 (1986), pp. 640-647
[23.]
D.C. Heiner.
IgG subclass deficiencies: identifying and treating patients at risk.
Vox Sang, 51 (1986), pp. 57-62
[24.]
L.J. Beard, A. Ferrante.
IgG4, deficiency in IgA-deficient patients.
Pediatr Infect Dis, 8 (1989), pp. 705-709
[25.]
T. Klemola, I. Seppala, E. Savilahti.
Serum IgG subclass levels in paediatric patients with variable degrees of IgA deficiency.
J Clin Immunol, 25 (1988), pp. 29-34
[26.]
L.J. Beard, A. Ferrante, V.A. Oxelius, G.M. Maxwell.
IgG subclass deficiency in children with IgA deficiency presenting with recurrent or severe respiratory infections.
Pediatr Res, 20 (1986), pp. 937-942
[27.]
R.H. Buckley, R.I. Schiff.
The use of intravenous immune globulin in immunodeficiency diseases.
N Engl J Med, 325 (1991), pp. 110-117
[28.]
Chapel, HM., for the consensus panel for the diagnosis, management of primary antibody deficiencies.
Consensus on diagnosis and management of primary antibody deficiencies.
Br Med J, 308 (1994), pp. 581-585
[29.]
K.E. Stein.
Thymus-independent and thymus-dependent responses to polysaccharide antigens.
J Infect Dis, 165 (1992), pp. 49-52
[30.]
D.M. Musher, J.E. Groover, J.M. Rowland, D.A. Watson, J.B. Struewing, R.E. Baughn, et al.
Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination.
Clin Infect Dis, 17 (1993), pp. 66-73
[31.]
E.S. Go, Z.K. Bailas.
Anti-pneumococcal antibody response in normal subjects: a meta-analysis.
J Allergy Clin Immunol, 98 (1996), pp. 205-215
[32.]
R.L. Wasserman.
Antibody deficiency: IgG subclass deficiency and vaccine nonresponder States.
Pediatr Infec Dis, 9 (1990), pp. 424-433
[33.]
D. Goldblatt, L.P. Jadresic, R.J. Levinsky, M.W. Tumer.
Antibody responses to pneumococcal capsular polysaccharides: what is being measured?.
Immunodeficiency, 4 (1993), pp. 47-50
[34.]
F. Mascart-Lemone, M. Gérard, M. Libin, A. Crusiaux, P. Franchioly, A. Lambrechts, et al.
Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine.
J Infect Dis, 172 (1995), pp. 1.253-1.260
[35.]
W.Y. Wong, G.D. Overturf, D.R. Powars.
Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, inmmunologic mechanism, prophylaxis and vaccinadon.
Clin Infect Dis, 14 (1992), pp. 124-136
[36.]
F.P. Kroon, J.T. Van Dissel, J.C. De Long, R. Van Furth.
Antibody response to influenza, tetanus and pneumococcal vaccines in HIVseropositive individuals in relation to the number of CD4+ lymphocytes.
AIDS, 8 (1994), pp. 469-476
[37.]
J.U. Hedlund, M.E. Kalin, A.B. Órtqvist, J. Henrichsen.
Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
Arch Intern Med, 154 (1994), pp. 1.961-1.965
[38.]
U. Sankilampi, P.O. Honkanen, A. Bloigu, E. Herva, M. Leinonen.
Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
J Infect Dis, 173 (1996), pp. 387-393
[39.]
M.J. Rodrigo, M. Miravitlles, M.J. Cruz, J. De Gracia, M. Vendrell, C. Pascual, et al.
Characterizadon of specific immunoglobulin G (IgG) and its subclasses (IgG 1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population. Proposal for response criteria.
Clin Diag Lab Immunol, 4 (1997), pp. 168-172
[40.]
D.M. Ambrosino, G. Schiffman, E.C. Gotschlich, P.H. Schur, G.A. Rosenberg, G.G. DeLange, et al.
Correlation between G2m (n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
J Clin Invest, 75 (1985), pp. 1.935-1.942
[41.]
H.B. Konradsen, J. Henrichsen, H. Wachmann, N. Holm.
The influence of genetic factors on the immune response as judged by pneumococcal vaccination of mono- and dizygotic Caucasian twins.
Clin Exp Immunol, 92 (1993), pp. 532-536
[42.]
S.J. Cryz, E. Fürer, T. Fredeking, A.S. Cross, J.C. Sadoff, J.U. Que.
Effect of race and blood group on the immune response to bacterial polysaccharide and conjugated vaccines.
Lancet, 10 (1989), pp. 1.533-1.534
[43.]
S.W. Hosea, C.G. Burch, E.J. Brown, R.A. Berg, M.M. Frank.
Impaired immune response of splenectomised patients ot polyvalent pneumococcal vaccine.
Lancet, 1 (1981), pp. 804-807
[44.]
M. Rodríguez Barradas, D.M. Musher, C. Lahart, C. Lacke, J. Groover, D. Watson, et al.
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infccted subjects with 23-valent pneumococcal vaccine.
J Infect Dis, 165 (1992), pp. 553-556
[45.]
P.J. Weiss, M.R. Wallace, E.C. Oldfield III, J. O’Brien, E.N. Janoff.
Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.
J Infect Dis, 171 (1995), pp. 1.217-1.222
[46.]
D.M. Muscher, D.A. Watson, E.A. Domínguez.
Pneumococcal vaccination: work to date and future prospects.
Am J Med Sci, 300 (1990), pp. 45-52
[47.]
M.C. Rodríguez-Barradas, J.E. Groover, C.E. Lacke, D.W. Gump, C.J. Lahart, J.P. Pandey, et al.
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in respondeos, revaccination in nonresponders, and relationship of immunoglobulin allotype to response.
J Infect Dis, 173 (1996), pp. 1.347-1.353
[48.]
J.B. Robbins, J.C. Parke Jr., R. Schneerson, J.K. Whisnant.
Quantitative measurement of “natural” and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.
Pediatr Res, 7 (1973), pp. 103-110
[49.]
D.H. Smith, G. Peters, D.L. Ingram, A.L. Harding, P. Anderson.
Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae type b.
Pediatrics, 52 (1975), pp. 637-644
[50.]
D.T. Umesu, D.M. Ambrosino, I. Quinti, G.R. Siber, R.S. Geha.
Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency.
N Engl J Med, 313 (1985), pp. 1.247-1.251
[51.]
R.S. Geha.
IgG antibody response to polissacharides in children with recurrent infections.
Monogr Allergy, 23 (1988), pp. 97-102
[52.]
B. Herer, F. Labrousse, M. Mordelet-Dambrine, A. Durandy, C. Offredo-Hemmer, O. Ekindjian, et al.
Selective IgG subclass deficiencies and antibody responses to pneumococcal capsular polysaccharide antigen in adult community-adquired pneumonía.
Am Rev Respir Dis, 142 (1990), pp. 854-857
[53.]
D. Musher, M.J. Luchi, D. Watson, R. Hamilton, R. Baughn.
Pneumococcal polysaccharide vaccine in young adults and older bron-chitics: Determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.
J Infect Dis, 161 (1990), pp. 728-735
[54.]
A. Virolainen, J. Jero, H. Käythy, P. Karma, M. Leinonen, J. Eskola.
Nasopharyngeal antibodies to pneumococcal capsular polysaccharides in children with acute otitis media.
J Infect Dis, 172 (1995), pp. 1.115-1.118
[55.]
U. Nordin, K. Wannfors, P. Colque-Navarro, R. Möllby, A. Heimdahl.
Antibody response in patients with osteomyelitis of the mandible.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 79 (1995), pp. 429-435
[56.]
M. McKinley, S. Leibowitz, R. Bronzo, I. Zanzi, G. Weissman, G. Schiffman.
Appropriate response to pneumococcal vaccine in celiac sprue.
J Clin Gastroenterol, 20 (1995), pp. 113-116
[57.]
M. Miravitlles, J. De Gracia, M.J. Rodrigo, R. Vidal, M. Torrella, M.J. Cruz, et al.
Immune response to pneumococcal polysaccharides (PP) following immunization of alpha-1-antitrypsin (AAT) deficiency patients.
Am J Respir Crit Care Med, 153 (1996), pp. A535
[58.]
J.P. Michalski, C.C. McCombs, E. Scopelitis, J.J. Biundo, T.A. Medsger.
Alpha-1-antitrypsin phenotypes including M subtypes in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis.
Arthritis Rheum, 29 (1986), pp. 586-591
[59.]
B.K. Edmonds, J.A. Hodge, R.L. Rietschel.
Alpha-1-antitrypsin deficiency-associated panniculitis: case report and review of the literature.
Pediatr Dermatol, 8 (1991), pp. 296-299
[60.]
S.N. Breit, D. Wakefield, J.P. Robinson, E. Luckhurst, P. Clark, R. Penny.
The role of alpha-1-antitrypsin deficiency in the pathogenesis of immune disorders.
Clin Immunol Immunopathol, 35 (1985), pp. 363-380
[61.]
M. Miravitlles, R. Vidal, J. De Gracia.
Ensiema por déficit de alfa1-antitripsina. Situación actual y nuevas perspectivas para el tratamiento.
Arch Bronconeumol, 28 (1992), pp. 296-302
[62.]
M. Miravitlles, R. Vidal, M. Torrella, J.M. Bofill, M. Cotrina, J. De Gracia.
Evaluación del tratamiento sustitutivo del enfisema por déficit de alfa-1-antitripsina.
Arch Bronconeumol, 40 (1994), pp. 479
[63.]
I. Blanco Blanco, M.L. Menéndez Gutiérrez, F. Carro del Camino.
Bronquiectasias extensas como manifestación única de un defecto grave de alfa-1-antitripsina.
Arch Bronconeumol, 28 (1992), pp. 253
[64.]
M. Miravitlles.
Resposta específica d’anticossos enfront de la vacuna penumocòcica en població adulta sana i malats amb patologia pulmonar infecciosa [tesis doctoral].
Universitat Autónoma, (1997),
Copyright © 1998. Sociedad Española de Neumología y Cirugía Torácica
